期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

垂体腺瘤中存活素和E-钙黏附蛋白及Ki-67的表达与其侵袭性的关系 被引量：1

原文传递
导出
摘要 垂体腺瘤是垂体前叶细胞形成的良性肿瘤，当伴有鞍区局部硬膜和骨质的侵犯及破坏时，称之为侵袭性垂体腺瘤，它是介于良性肿瘤和腺癌之间的、具有恶性肿瘤生物学行为的肿瘤，手术切除后容易复发。由于它的诊断不能以肿瘤细胞的异型性和核分裂来判断，且电镜检查与非侵袭性腺瘤肜态也相似，
作者 王淳良 梅金红 万红萍 陈任生 徐林林
机构地区 南昌大学第一附属医院神经外科 南昌大学第一附属医院病理科
出处 《中华病理学杂志》 CAS CSCD 北大核心 2008年第5期335-336,共2页 Chinese Journal of Pathology
关键词 侵袭性垂体腺瘤 KI-67 存活素 白及 黏附 良性肿瘤 生物学行为 手术切除后
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献7

  • 1Cottier JP, Destrieux C, Brunereau L, et al. Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology, 2000, 215(2) : 463-469.
  • 2王忠诚.神经外科学[M].武汉:湖北科学技术出版社,1997.689.
  • 3Mastronardi L, Guiducci A, Spera C, et al. Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J Clin Pathol, 1999, 52(2) :107-111.
  • 4Wolfsberger S, Kitz K, Wunderer J, et al. Muhiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas. Acta Neurochir (Wien) , 2004, 146 ( 12 ) : 1323-1327.
  • 5Shankar SI, Mani S, O'Guin KN, et al. Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways. J Neurochem, 2001, 79 (2) :426-436.
  • 6Ikeguchi M, Ueda T, Sakatani T, et al. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol, 2002,11 ( 1 ) :33-40.
  • 7Shun CT, Wu MS, Lin MT, et al. Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and Helicobacter pylori infection. Oncology, 2001, 60 (4) :339-345.

共引文献73

同被引文献29

  • 1聂明豪,杜明,李秀荣.细胞角蛋白19及Ki67在甲状腺乳头状癌中的表达[J].黑龙江医学,2005,29(3):168-169. 被引量：4
  • 2李晓明.血管内皮细胞生长因子及其受体与肿瘤血管形成[J].国外医学（肿瘤学分册）,1997,24(1):11-13. 被引量：54
  • 3Hegedüs L.Clinical Practice:the Thyroid Nodule[J].N Engl J Med,2004,351(17):1764-1771.
  • 4Shaha A R.Controversies in the Management of Thyroid Nodule[J].Laryngoscope,2000,110(2 Pt l):183-193.
  • 5Hay I D,Thompson G B,Grant C S,et al.Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades(1940-1999):Temporal Trends in Initial Therapy and Long-term Outcome in 2444 Consecutively Treated Patients[J].World J Surg,2002,26(8):879-885.
  • 6Passler C,Scheuba C,Prager G,et al.Prognostic Factors of Papillary and Follicular Thyroid Cancer:Differences in an Iodine-Replete Endemic Goiter Region[J].Endocr Relat Cancer,2004,11(1):131-139.
  • 7Maeda K,Chung Y S,Ogawa Y,et al.Prognostic Value of Vascular Endothelial Growth Factor Expression in Gastric Carcinoma[J].Cancer,1996,77(5):858-863.
  • 8Yamamoto S,Konishi I,Mandai M,et al.Expression of Vascular Endothelial Growth Factor (VEGF) in Epithelial Ovarian Neoplasms:Correlation with Clinicopathology and Patient Survival,and Analysis of Serum VEGF Levels[J].Br J Cancer,1997,76(9):1221-1227.
  • 9Yuan A,Yu C J,Chen W J,et al.Correlation of Total VEGF mRNA and Protein Expression with Histologic Type,Tumor Angiogenesis,Patient Survival and Timing of Relapse in Non-small-cell Lung Cancer[J].Int J Cancer,2000,89(6):475-483.
  • 10Lewy Trenda I,Wierzchniewska Lawska A.Expression of Vascular Endothelial Growth Factor (VEGF) in Human Thyroid Tumors[J].Pol J Pathol,2002,53(3):129-132.

引证文献1

中华病理学杂志
2008年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部